CaMKK2 Knockout Bone Marrow Cells Collected/Processed in Low Oxygen (Physioxia) Suggests CaMKK2 as a Hematopoietic Stem to Progenitor Differentiation Fate Determinant
dc.contributor.author | Broxmeyer, Hal E. | |
dc.contributor.author | Ropa, James | |
dc.contributor.author | Capitano, Maegan L. | |
dc.contributor.author | Cooper, Scott | |
dc.contributor.author | Racioppi, Luigi | |
dc.contributor.author | Sankar, Uma | |
dc.contributor.department | Microbiology and Immunology, School of Medicine | |
dc.date.accessioned | 2023-11-29T18:30:40Z | |
dc.date.available | 2023-11-29T18:30:40Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Little is known about a regulatory role of CaMKK2 for hematopoietic stem (HSC) and progenitor (HPC) cell function. To assess this, we used Camkk2−/− and wild type (WT) control mouse bone marrow (BM) cells. BM cells were collected/processed and compared under hypoxia (3% oxygen; physioxia) vs. ambient air (~21% oxygen). Subjecting cells collected to ambient air, even for a few minutes, causes a stress that we termed Extra Physiological Shock/Stress (EPHOSS) that causes differentiation of HSCs and HPCs. We consider physioxia collection/processing a more relevant way to assess HSC/HPC numbers and function, as the cells remain in an oxygen tension closer physiologic conditions. Camkk2−/− cells collected/processed at 3% oxygen had positive and negative effects respectively on HSCs (by engraftment using competitive transplantation with congenic donor and competitor cells and lethally irradiated congenic recipient mice), and HPCs (by colony forming assays of CFU-GM, BFU-E, and CFU-GEMM) compared to WT cells processed in ambient air. Thus, with cells collected/processed under physioxia, and therefore never exposed and naïve to ambient air conditions, CaMKK2 not only appears to act as an HSC to HPC differentiation fate determinant, but as we found for other intracellular mediators, the Camkk−/− mouse BM cells were relatively resistant to effects of EPHOSS. This information is of potential use for modulation of WT BM HSCs and HPCs for future clinical advantage. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Broxmeyer HE, Ropa J, Capitano ML, Cooper S, Racioppi L, Sankar U. CaMKK2 Knockout Bone Marrow Cells Collected/Processed in Low Oxygen (Physioxia) Suggests CaMKK2 as a Hematopoietic Stem to Progenitor Differentiation Fate Determinant. Stem Cell Rev Rep. 2022;18(7):2513-2521. doi:10.1007/s12015-021-10306-8 | |
dc.identifier.uri | https://hdl.handle.net/1805/37231 | |
dc.language.iso | en_US | |
dc.publisher | Springer | |
dc.relation.isversionof | 10.1007/s12015-021-10306-8 | |
dc.relation.journal | Stem Cell Reviews and Reports | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | CaMKK2 | |
dc.subject | Hypoxia cell collection | |
dc.subject | Hematopoietic stem cells (HSCs) | |
dc.subject | Hematopoietic progenitor cells (HPCs) | |
dc.title | CaMKK2 Knockout Bone Marrow Cells Collected/Processed in Low Oxygen (Physioxia) Suggests CaMKK2 as a Hematopoietic Stem to Progenitor Differentiation Fate Determinant | |
dc.type | Article |